PECAM1 and malignant colon neoplasm: We previously found that the mesenchymal cell marker vimentin was strongly expressed, accompanied by a serious disappearance of PECAM-1, in the endothelium in human colon cancer with DM, comparing to that in CC without DM, which implies high-frequency EndMT events in CC with DM.